Streetbeat News

Stock Prices

API

Agora (NASDAQ:API) is scheduled to release its quarterly earnings report on February 26, 2024, with an expected EPS of $-0.09. Analysts and investors will be closely watching if Agora can surpass this estimate and provide positive guidance for the next quarter. Agora's stock performance has been negative over the last year, with a 28.52% decline, and past earnings misses have led to significant price drops. The company's past earnings performance shows a mixed record of beating and missing EPS estimates.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

CRI

Wedbush has maintained its Neutral rating on Carter's (NYSE:CRI) but raised its price target from $67.00 to $78.00. Despite this, Carter's shares are currently trading at $82.74, indicating a potential decline if the price adjusts to the new target. Carter's Inc specializes in children's apparel and operates through various sales channels in the U.S. and internationally, with a significant portion of its sales in the U.S.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

TRN

Susquehanna has maintained its Positive rating on Trinity Industries (NYSE:TRN) but lowered its price target from $32.00 to $30.00. Trinity Industries' shares are currently trading at $25.43, and a move to $30.00 would represent a 17.97% increase. Trinity Industries, operating under TrinityRail, is involved in the sale and lease of railroad products and railcar maintenance services in North America.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

ZD

Four analysts have recently updated their ratings on Ziff Davis (NASDAQ:ZD), showing a shift towards a more bullish outlook with three somewhat bullish and one indifferent rating. The average 12-month price target has been raised to $80.25, up from $72.00, indicating a positive sentiment shift. Despite this, Ziff Davis faces financial challenges, including a slight revenue decline, below-average net margin, and lower than industry benchmarks for ROE and ROA.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

DKS

Over the past 15 years, Dick's Sporting Goods (NYSE:DKS) has produced an average annual return of 19.64%, outperforming the market by 5.58%. A $100 investment in DKS 15 years ago would now be worth $1,385.34. The company currently has a market capitalization of $13.80 billion.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

FNF

Barclays has maintained its Equal-Weight rating on Fidelity National Finl (NYSE:FNF) but reduced its price target from $55.00 to $52.00. FNF's shares are currently up 0.16% at $50.05, and the new target suggests a potential 3.9% increase. FNF provides title insurance, escrow, and other title-related services primarily in the United States.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

LOW

Over the past 20 years, Lowe's Companies (NYSE:LOW) has produced an average annual return of 11.22%, outperforming the market by 3.53% annually. A $1000 investment in LOW 20 years ago would be worth $8,167.22 today. Lowe's has a current market capitalization of $133.05 billion, highlighting the impact of compounded returns over time.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

BORR

Evercore ISI Group has maintained its In-Line rating for Borr Drilling (NYSE:BORR) but lowered its price target from $10.00 to $9.00. Borr Drilling's shares are currently down 2.16% at $6.34. The new price target suggests a potential 41.96% increase from the current price. Borr Drilling is a drilling contractor with a fleet of 16 jack-up rigs, primarily operating in Norway.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

BHC

RBC Capital has maintained its Sector Perform rating for Bausch Health Companies (NYSE:BHC) and increased its price target from $8.00 to $9.00. BHC's shares are currently trading up 0.54% at $9.35, which is above the new target. Bausch Health is a global company focusing on branded products for dermatology, gastrointestinal, and ophthalmology markets, with Bausch + Lomb being its highest revenue segment.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 5:00 pm

ATNI

CVNA

MRVI

SQ

Carvana Co. reported Q4 results with revenue of $2.424 billion and a loss of $1 per share, missing estimates. The company expects Q1 retail units sold to slightly increase year-over-year and anticipates adjusted EBITDA significantly above $100 million. Shares surged 31.1%. Other stocks like Maravai LifeSciences, ATN International, and Block, Inc. also recorded significant gains following their financial results.

Portfolio Pulse from Avi Kapoor

February 23, 2024 | 4:59 pm